Furosemide is currently the only acknowledged therapy for exercise-induced lung hemorrhage.
Photo: Anne M. Eberhardt
The National Horsemen’s Benevolent and Safety Association (HBPA) reiterated its strong support for the continued use of furosemide (marketed as Salix and commonly called Lasix) at its summertime convention Aug.15-17 in Oklahoma City, Oklahoma.
Furosemide is presently the only acknowledged treatment for exercise-induced pulmonary hemorrhage (EIPH).
The National HBPA signs up with the Thoroughbred Horsemen’s Association, the Thoroughbred Owners of California, and the California Thoroughbred Trainers in supporting furosemide use in current statements. Together these 4 horsemen’s groups have nearly 50,000 owner and fitness instructor members who race in the United States and Canada.
Those attending the Oklahoma City convention heard a panel of country wide acknowledged experts stating that existing medical science does not support The Jockey Club’s call for prohibiting the race-day furosemide use. The HBPA says a ban would unavoidably be damaging to equines.
In June, The Jockey Club contacted industry stakeholders to come together to perform a study that would examine the timing of furosemide administration to avoid EIPH. The organization likewise has said it would pursue federal regulation towards a national policy on medication reform in racing.
Pulmonary bleeding is inextricably linked with steeds, and puts the wellness of horses and safety of jockeys at danger, the National HBPA specified in a release.
“Until a better therapy for this progressive illness is identified, there is no possible honest or humane reason for depriving racing steeds and their riders of the safety therapeutic advantages of Lasix.”.
About the Author.
The Blood-Horse Staff.
The Blood-Horse is the leading weekly publication devoted to global Thoroughbred racing and breeding. Considering that 1916, the staff of The Blood-Horse has actually served the Thoroughbred neighborhood with the highest standards of journalistic quality to provide detailed and timely editorial coverage and analysis.